Publications by authors named "Mathieu Spaas"

Claim this Profile
M
Microbiome and metabolome dynamics during radiotherapy for prostate cancer.
Willeke Danckaert, Mathieu Spaas, Nora Sundahl, Aurélie De Bruycker, Valérie Fonteyne

Radiother Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors: The CHEERS Phase 2 Randomized Clinical Trial.
Mathieu Spaas, Nora Sundahl, Vibeke Kruse, Sylvie Rottey, Daan De Maeseneer

JAMA Oncol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of radiotherapy parameters on the risk of lymphopenia in urological tumors: A systematic review of the literature.
Willeke Danckaert, Mathieu Spaas, Katrien Vandecasteele, Carlos De Wagter, Piet Ost

Radiother Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re: Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study.
Mathieu Spaas, Nora Sundahl, Piet Ost

Eur Urol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Relevance of Serum Kyn/Trp Ratio and Basal and IFNγ-Upregulated IDO1 Expression in Peripheral Monocytes in Early Stage Melanoma.
Annabel Meireson, Liesbeth Ferdinande, Marc Haspeslagh, Benjamin Hennart, Delphine Allorge, Mathieu Spaas

Front Immunol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A fatal wound complication following sequential anti-angiogenesis, immune checkpoint inhibition and ultra-hypofractionated radiotherapy.
Miha Orazem, Cédric Draulans, Mathieu Spaas, Eric Van Cutsem, Marina Debecker

Clin J Gastroenterol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spatiotemporal Evolution of Radiation Myositis on 18F-FDG PET/CT Following Hypofractionated Radiotherapy of Intramuscular Melanoma Metastases.
Mathieu Spaas, Bliede Van den Broeck, David Creytens, Vibeke Kruse, Piet Ost

Clin Nucl Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.
Mathieu Spaas, Nora Sundahl, Eva Hulstaert, Vibeke Kruse, Sylvie Rottey

BMC Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune Monitoring in Melanoma and Urothelial Cancer Patients Treated with Anti-PD-1 Immunotherapy and SBRT Discloses Tumor Specific Immune Signatures.
Annabel Meireson, Simon J Tavernier, Sofie Van Gassen, Nora Sundahl, Annelies Demeyer, Mathieu Spaas

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the Combination of Immunotherapy and Radiotherapy in Non-small Cell Lung Cancer a Feasible and Effective Approach?
Mathieu Spaas, Yolande Lievens

Front Med (Lausanne)· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Value of Stimulated Thyroglobulin Levels at the Time of Radioiodine Administration in Differentiated Thyroid Cancer.
Mathieu Spaas, Brigitte Decallonne, Annouschka Laenen, Jaak Billen, Sandra Nuyts

Eur Thyroid J· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis